X-Chem has released its XD3 drug discovery technology. The solution reportedly combines data generated by DNA-encoded library (DEL) screening, the company’s ArtemisAI artificial intelligence platform, and chemistry experience.
“The generation of large datasets and artificial intelligence are transforming drug discovery,” said X-Chem CEO Matt Clark. “We believe our XD3 Dynamic Drug Discovery ecosystem will maximally leverage our state-of-the-art technology in the pursuit of innovative drugs for novel and difficult disease targets. We want to transform the drug discovery process to bring drug hunters from target-to-clinical candidate at unparalleled speed.”